Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. The company offers PocketECG, a diagnostic solution for the diagnosis of arrhythmia that provides disclosure ECG signal, complete data, analysis, and comprehensive reporting; and PocketECG CRS for cardiac rehabilitation monitoring. It also provides ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal; PatchECG, a device enabling single-channel offline monitoring; and PocketECG IV that enables the PocketECG to be connected over the LTE band for continuous ECG signal transmission. In addition, the company offers information technology, biotechnology, ECG monitoring, and scientific research and development services; and manufactures and sells electro-medical equipment. Medicalgorithmics S.A. was founded in 2005 and is headquartered in Warsaw, Poland.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E.
Target Price
The average target price of MDG.WA is 44 and suggests 66% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell